From

Institution

Field

Type

Topic: Treatment of Major Depression ×

Open access only Cited by patents (Lens) Include non-Aachen papers (citing/cited)

Reset

Papers matching “antidepressant effects” in Treatment of Major Depression 21

Sort: Relevance Cited Newest Oldest Fwci Patents ⇩ CSV

Not finding it? Sign in to also search OpenAlex live.

Letter to the editor regarding “A Novel, Brief, Fully Automated Intervention to Extend the Antidepressant Effect of a Single Ketamine Infusion: A Randomized Clinical Trial”
2022 preprint Medicine Treatment of Major Depression Open access

Ioana A. Cristea, Florian Naudet, Eiko I. Fried

0

citations
Increase in thalamic cerebral blood flow is associated with antidepressant effects of ketamine in major depressive disorder
2022 The World Journal of Biological Psychiatry article Medicine Treatment of Major Depression Open access

Matti Gärtner, Mischa de Rover, Lena Václavů, Milan Scheidegger, Matthias J.P. van Osch, Simone Grimm

11

citations
Sustained pharmacodynamic effects of S‐ketamine on cortical excitability and resting‐state brain activity: A randomized, placebo‐controlled trial
2026 British Journal of Clinical Pharmacology article Medicine Treatment of Major Depression Open access

Catherine M.K.E. de Cuba, Annika A. de Goede, Joost van Mechelen, Laura G. J. M. Borghans, Lazarenko Aa, Erik Olofsen, +6 more

0

citations
Pharmacokinetics and pharmacodynamics of intravenous and oral (S)‐ketamine: Investigating metabolite contribution to subjective effects
2026 British Journal of Clinical Pharmacology article Medicine Treatment of Major Depression Open access

Marije E. Otto, Gabriël E. Jacobs, Joost van Mechelen, Laura G. J. M. Borghans, Johan G.C. van Hasselt, Linda B. S. Aulin

0

citations
Ketamine effects on resting state functional brain connectivity in major depressive disorder patients: a hypothesis-driven analysis based on a network model of depression
2025 Frontiers in Neuroscience article Medicine Treatment of Major Depression Open access

Kasper Recourt, Joop van Gerven, Nadieh Drenth, Jeroen van der Grond, Kantaro Nishigori, Nic JA van der Wee, +1 more

1

citations
Acute effects of lithium augmentation on the kidney in geriatric compared with non‐geriatric patients with treatment‐resistant depression
2022 Acta Psychiatrica Scandinavica article Medicine Treatment of Major Depression Open access

Sarah Luise Osterland, Mazda Adli, Turgay Saritas, Peter Schlattmann, Joachim Behr, Ronja Müller‐Mertel, +10 more

6

citations
Regional brain morphology and current antidepressant use: findings from 32 international cohorts from the ENIGMA major depressive disorder working group
2025 Molecular Psychiatry article Medicine Treatment of Major Depression Open access

Chaira Serrarens, Yara Jo Toenders, Elena Pozzi, André Alemán, Nina Alexander, Zeynep Başgöze, +93 more

3

citations
Effect of Minocycline on Depressive Symptoms in Patients With Treatment-Resistant Depression
2022 JAMA Network Open article Medicine Treatment of Major Depression Open access

Julian Hellmann‐Regen, Michael Grözinger, Johannes Kornhuber, Andreas Reif, David Prvulovic, Roberto Goya‐Maldonado, +12 more

100

citations
Characterization of the central nervous system penetrant and selective purine P2X7 receptor antagonist JNJ-54175446 in patients with major depressive disorder
2023 Translational Psychiatry article Medicine Treatment of Major Depression Open access

Kasper Recourt, Peter de Boer, Peter D van der Ark, Heike Beneš, Joop van Gerven, Marc Ceusters, +5 more

67

citations
Pharmacokinetics and pharmacodynamics of orally administered S-ketamine in healthy participants
2026 Journal of Psychopharmacology article Medicine Treatment of Major Depression Open access

Joost van Mechelen, Tobias Wieles, Laura G. J. M. Borghans, Marije E. Otto, Maria Joanna Juachon, Amy L. Gillespie, +5 more

2

citations
Selective Serotonin Reuptake Inhibitors within Cells: Temporal Resolution in Cytoplasm, Endoplasmic Reticulum, and Membrane
2023 Journal of Neuroscience article Medicine Treatment of Major Depression Open access

Aaron L. Nichols, Zack Blumenfeld, Laura Luebbert, Hailey J. Knox, Anand K. Muthusamy, Jonathan S. Marvin, +9 more

16

citations
Pharmacokinetics and pharmacodynamics of orally administered S-ketamine in a randomized controlled trial in healthy participants
2025 preprint Medicine Treatment of Major Depression Open access

Joost van Mechelen, Tobias Wieles, Laura G. J. M. Borghans, Marije E. Otto, Maria Joanna Juachon, Amy L. Gillespie, +5 more

1

citations
Pharmacokinetic correlates of clinical response in a naturalistic sample of escitalopram-treated patients
2024 Expert Review of Clinical Pharmacology article Medicine Treatment of Major Depression

Nicholas Kasperk, Ekkehard Haen, Christoph Hiemke, Thomas Frodl, Georgios Schoretsanitis, Michael Paulzen, +1 more

1

citations
The lipid landscape shapes the immunomodulatory potential of fluoxetine in macrophages
2026 bioRxiv (Cold Spring Harbor Laboratory) preprint Medicine Treatment of Major Depression Open access

Jill Grondelaers, Ashleigh Jimenez-Lemus, Lieve Temmerman, Erik A.L. Biessen, Ronit Shiri‐Sverdlov, Emiel P. C. van der Vorst, +1 more

0

citations
Citalopram-induced pathways regulation and tentative treatment-outcome-predicting biomarkers in lymphoblastoid cell lines from depression patients
2020 Translational Psychiatry article Medicine Treatment of Major Depression Open access

Abdul Karim Barakat, Catharina Scholl, Michael Steffens, Kerstin Brandenburg, Marcus Ising, Susanne Lucae, +4 more

9

citations
Contributing factors to advanced brain aging in depression and anxiety disorders
2021 Translational Psychiatry article Medicine Treatment of Major Depression Open access

Laura K. M. Han, Hugo Gerard Schnack, Rachel M. Brouwer, Dick J. Veltman, Nic J.A. van der Wee, Marie‐José van Tol, +2 more

81

citations
Brain aging in major depressive disorder
2021 European Psychiatry article Medicine Treatment of Major Depression Open access

Laura K. M. Han, Hugo Gerard Schnack, Rachel M. Brouwer, Dick J. Veltman, Nic J.A. van der Wee, Marie‐José van Tol, +2 more

1

citations
MTORC1 signaling as a biomarker in major depressive disorder and its pharmacological modulation by novel rapid-acting antidepressants
2021 Therapeutic Advances in Psychopharmacology article Medicine Treatment of Major Depression Open access

Tomasz Cholewinski, Matthijs Moerland, Gabriël E. Jacobs

19

citations
Dissecting heterogeneity in cortical thickness abnormalities in major depressive disorder: a large-scale ENIGMA MDD normative modelling study
2025 bioRxiv (Cold Spring Harbor Laboratory) preprint Medicine Treatment of Major Depression Open access

Johanna Bayer, Laura S. van Velzen, Elena Pozzi, Christopher G. Davey, Laura K. M. Han, Stéphanie Bauduin, +35 more

6

citations
Utility of therapeutic drug monitoring in the treatment of major depressive disorder
2025 Current Opinion in Psychiatry article Medicine Treatment of Major Depression Open access

Georgios Schoretsanitis, Michael Paulzen

2

citations
Nitric Oxide Donor Sodium Nitroprusside Reduces Racemic Ketamine─But Not Esketamine-Induced Pain Relief
2024 ACS Pharmacology & Translational Science article Medicine Treatment of Major Depression Open access

Albert Dahan, Simone C. Jansen, Rutger M. van der Schrier, Elise Y. Sarton, David Dadiomov, Monique van Velzen, +2 more

9

citations

21 results